MiR-128-1 is continuously inhibited in hyperlipidaemic Apoe/mice, resulting in a significant reduction in hepatic steatosis, VLDL-associated TAGs and circulating VLDL-C/LDL-C. The gene discussed is APOE; the disease is fatty liver disease.